GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 10, 2023 at 04:44 pm EST
Share
GeneFerm Biotechnology Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 195.17 million compared to TWD 166.14 million a year ago. Net income was TWD 33.86 million compared to TWD 25.47 million a year ago. Basic earnings per share from continuing operations was TWD 0.82 compared to TWD 0.61 a year ago. Diluted earnings per share from continuing operations was TWD 0.81 compared to TWD 0.61 a year ago.
For the nine months, sales was TWD 610.82 million compared to TWD 463.77 million a year ago. Net income was TWD 111.14 million compared to TWD 76 million a year ago. Basic earnings per share from continuing operations was TWD 2.68 compared to TWD 1.84 a year ago. Diluted earnings per share from continuing operations was TWD 2.67 compared to TWD 1.78 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.